TEVA PHARMACEUTICAL INDUSTRIES LTD (NYSE:TEVA) filed its annual report (Form 10-K) with the Securities and Exchange Commission on February 03, 2026. The Healthcare company…
TEVA PHARMACEUTICAL INDUSTRIES LTD (NYSE:TEVA) filed its annual report (Form 10-K) with the Securities and Exchange Commission on February 03, 2026.
The Healthcare company reported annual revenue of and net income of for fiscal year 0.
TEVA PHARMACEUTICAL INDUSTRIES LTD's stock currently trades at $36.25 with a market capitalization of $34.6B.
Our Markets Team monitors market data, SEC filings, analyst actions, earnings releases, and corporate announcements to produce timely updates for investors.
Current market data
NYSE · TEVA
Keep reading
institutional ·
institutional ·
institutional ·
institutional ·
